This compound, the sodium salt of (3S,5R,E)-7-(3-(4-fluorophenyl)-1-isopropyl-1H-indol-2-yl)-3,5-dihydroxyhept-6-enoic acid, is a statin drug primarily utilized in the pharmaceutical industry for managing cholesterol levels. Its structure is crucial for inhibiting HMG-CoA reductase, an enzyme involved in cholesterol production in the liver. By blocking this enzyme, it helps reduce LDL (bad cholesterol) and triglycerides while increasing HDL (good cholesterol), thereby lowering the risk of cardiovascular diseases. Additionally, its specific stereochemistry enhances its efficacy and selectivity, making it a valuable therapeutic agent for hyperlipidemia and related conditions. It is often prescribed in conjunction with lifestyle modifications such as diet control and exercise.